Brett A. Giffin - 20 Feb 2023 Form 4/A - Amendment Insider Report for T2 Biosystems, Inc. (TTOO)

Role: Chief Commercial Officer
Signature: /s/ John Sprague, Attorney-in-fact
Issuer symbol: TTOO
Transactions as of: 20 Feb 2023
Net transactions value: -$349
Form type: 4/A - Amendment
Filing time: 28 Nov 2023, 16:00:04 UTC
Date Of Original Report: 09 Mar 2023
Previous filing: 22 Nov 2022
Next filing: 28 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TTOO	Common Stock	Options Exercise		+1,333	+59%		3,586	20 Feb 2023	Direct	F1, F2
transaction	TTOO	Common Stock	Sale	$349	-537	-15%	$0.6500	3,049	20 Feb 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TTOO	Restricted Stock Units	Options Exercise	$0	-1,333	-33%	$0.000000	2,667	20 Feb 2023	Common Stock	1,333		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	The original Form 4 filed on March 9, 2023 is amended by this Form 4 amendment to correct the amount of securities beneficially owned following the reported transactions.
F3	The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person adopted by the reporting person on November 10, 2021.
F4	On February 20, 2022 the reporting person was granted 4,000 RSU's that vest in three equal annual installments commencing on February 20, 2023.